Important note: Information in this article was accurate in 2002. The state of the art may have changed since the publication date.
Important note: Information in this article was accurate in 2002. The state of the art may have changed since the publication date.
Reuters NewMedia - October 22, 2002
GENEVA -- Life-saving medicines are not available to one-third of the world's population despite a long international campaign for wider access to essential drugs, the World Health Organization said Monday.
In the 25 years since WHO drew up its essential drugs and medicines list, the number of people able to obtain those medicines has doubled, but there remains "a huge unfinished agenda," said Jonathan Quick, the head of the U.N. agency's project.
"We still have 2 billion people who can't regularly get medicines when they need them, at a quality they trust and at a price they or their community can afford," Quick told health experts at a discussion attended by journalists.
The U.N. health agency's list includes more than 300 medicines and aims to guide mainly Third World governments and health bodies on what drugs should be available, at what quality and price and in what dosage.
In poor countries, where a daily income of $1 or $2 is the norm, the burden of financing health care often falls on those who are sick.
WHO Director General Gro Harlem Brundtland said so-called out-of-pocket payments by patients account for as much as 90% of total health care spending in some poor countries.
"For many, the reality is stark: No cash, no cure," she said.
Bernard Pecoul of Doctors Without Borders said patents, particularly on AIDS treatments, translate into high prices, "with the direct result that people in developing countries cannot afford to save their own lives."
"We cannot accept the sick logic that says he who cannot pay, dies," he said.
021022
RE021030
Copyright © 2002 - Reuters, Ltd. All rights reserved. Republication or redistribution of Reuters content is expressly prohibited without the prior written consent of Reuters. Reuters shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon. Contact Reuters.
AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Broadway Cares/Equity Fights AIDS, Elton John AIDS Foundation, the National Library of Medicine, Pacific Life Foundation and donations from users like you.
Always watch for outdated information. This article first appeared in 2002. This material is designed to support, not replace, the relationship that exists between you and your doctor.
AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.
Copyright ©1980, 2002. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .